Sunesis Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 90   

Articles published

SNSS 1.21 0.00 (-0.01%)
price chart
Companies With High EPS Growth: Sunesis Pharmaceuticals, Inc. (SNSS), Memorial ...
Analysts gives Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) a mean recommendation of 3.00. The company has declined -48.95% in past 3 months.
Company Shares of Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Rally 6.14%  News Watch International
Biotech Stocks: Here's Where to Get In- Sunesis Pharmaceuticals, Inc ...  Wall Street Point
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Price Target Update
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) stock has received a short term price target of $ 1.9 from 5 Analyst. The share price can be expected to fluctuate from the mean short term target, can be seen from the standard deviation reading of $0.74.
Most Volatile Stocks: Noble Corporation plc (NE), Sunesis Pharmaceuticals ...  WallStreet Scope
Significant Insider Buying Activity: Shutterstock Inc (NYSE:SSTK), Green ...  Wall Street Point
GPM Announces Investigation of Sunesis Pharmaceuticals, Inc.
LOS ANGELES, Jul 27, 2015 (BUSINESS WIRE) -- Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of investors of Sunesis Pharmaceuticals, Inc. ("Sunesis" or the "Company") SNSS, +14.15% The investigation concerns whether ...
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Short Interest Update  Money Flow Index
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) faces Investor Investigation ...  OctaFinance.com
Sunesis Pharmaceuticals, Inc. Short Interest Update
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) has shown a rise of 15.7% or 626,268 shares in the short positions. The bets have increased to 4,609,166 shares on August 14,2015 from 3,982,898 shares on July 31,2015.
Sunesis Pharmaceuticals Inc (SNSS) Files Form 4 Insider Buying : Daniel N Jr ...  Insider Trading Report
Sunesis Pharmaceuticals Receives Average Recommendation of "Hold" ...  sleekmoney
Sunesis Pharmaceuticals, Inc. (SNSS) Shares March Higher, Can It Continue?
Sunesis Pharmaceuticals, Inc. (SNSS - Snapshot Report) has been on the move lately as the stock has risen by 27.6% in the past four weeks, and it is currently trading well above its 20-Day SMA.
Sunesis Pharmaceuticals Inc. (SNSS) Drops 9.65% on August 24
Sunesis Pharmaceuticals Inc. (SNSS) was one of the Russell 2000's biggest losers for Monday August 24 as the stock slid 9.65% to $1.03, a loss of $-0.11 per share.
FDA seeks more clinical evidence on Sunesis Pharma cancer drug
Sunesis Pharmaceuticals Inc said the U.S. Food and Drug Administration called for more clinical evidence before considering approval for its cancer drug, sending the company's shares down 60 percent in after-market trading.
Cantor Fitzgerald Downgrades Sunesis Pharmaceuticals Inc. (SNSS) to Hold  StreetInsider.com
Stocks of Sunesis Pharmaceuticals Inc. (NASDAQ:SNSS) Lost 70 Percent  WallStreet.org
Investigation of Sunesis Pharmaceuticals, Inc. Announced by The Law Offices of ...
BENSALEM, Pa., Jul 24, 2015 (BUSINESS WIRE) -- Law Offices of Howard G. Smith announces an investigation on behalf of investors of Sunesis Pharmaceuticals, Inc. ("Sunesis" or the "Company") SNSS, -9.65% The investigation concerns whether the ...
Sunesis Pharmaceuticals, Inc. Price Target Update
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) should head towards $1.9 per share according to 5 Analysts in consensus.
Can Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Surprise Analysts this Quarter?  Investor Newswire
Zacks Short Term Rating on Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) has received a short term rating of hold from research analysts at Zacks with a rank of 3. The company has been rated an average of 3.57 by 7 Wall Street Analysts.